Zevra Therapeutics Inc (ZVRA)
4.73
-0.03
(-0.63%)
USD |
NASDAQ |
May 17, 16:00
4.73
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Total Assets (Quarterly): 151.28M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 151.28M |
| December 31, 2023 | 172.33M |
| September 30, 2023 | 138.98M |
| June 30, 2023 | 105.52M |
| March 31, 2023 | 106.60M |
| December 31, 2022 | 115.34M |
| September 30, 2022 | 119.55M |
| June 30, 2022 | 124.26M |
| March 31, 2022 | 125.71M |
| December 31, 2021 | 132.94M |
| September 30, 2021 | 137.19M |
| June 30, 2021 | 138.80M |
| March 31, 2021 | 90.44M |
| December 31, 2020 | 11.21M |
| September 30, 2020 | 11.20M |
| June 30, 2020 | 12.33M |
| March 31, 2020 | 8.885M |
| December 31, 2019 | 10.51M |
| September 30, 2019 | 12.89M |
| Date | Value |
|---|---|
| June 30, 2019 | 13.01M |
| March 31, 2019 | 19.87M |
| December 31, 2018 | 26.75M |
| September 30, 2018 | 18.74M |
| June 30, 2018 | 34.00M |
| March 31, 2018 | 42.65M |
| December 31, 2017 | 52.46M |
| September 30, 2017 | 59.31M |
| June 30, 2017 | 69.05M |
| March 31, 2017 | 75.64M |
| December 31, 2016 | 84.89M |
| September 30, 2016 | 94.54M |
| June 30, 2016 | 104.63M |
| March 31, 2016 | 111.94M |
| December 31, 2015 | 54.59M |
| September 30, 2015 | 61.42M |
| June 30, 2015 | 66.54M |
| March 31, 2015 | 14.12M |
| December 31, 2014 | 13.71M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.885M
Minimum
Mar 2020
172.33M
Maximum
Dec 2023
86.95M
Average
110.97M
Median
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 278.29M |
| Dare Bioscience Inc | 13.01M |
| OptiNose Inc | 83.71M |
| Kodiak Sciences Inc | 434.76M |
| INmune Bio Inc | 46.83M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 102.46M |
| Shareholders Equity (Quarterly) | 48.82M |
| Debt to Equity Ratio | 0.8808 |
| Current Ratio | 2.103 |
| Net Debt Paydown Yield | -2.49% |